In the realm of drug development, histology is essential for preclinical and clinical studies. It helps in the evaluation of drug toxicity, efficacy, and mechanism of action. During preclinical trials, histological analysis of animal models can reveal potential adverse effects on various organs and tissues, guiding the optimization of drug formulations. In clinical trials, histological data from biopsies can provide early indicators of treatment success or failure, facilitating the swift modification of therapeutic strategies.
